Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological standardization of Platanus acerifolia allergen extract
2012-001938-34Phase 2Active
- Sponsor
- LETI Pharma
- Start
- Aug 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of platanus acerifolia allergen extract in pollinosis, sponsored by LETI Pharma. Primary endpoint: Wheal size area. Started Aug 2012; status: active.
02
Drugs
platanus acerifolia allergen extract
03
Conditions
pollinosis
Beyond the preview
Go deeper on 2012-001938-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001938-34.